文章对国内不同地区8台无后处理设备和2台带有后处理设备的火化炉烟气中二噁英类的排放情况进行了研究。结果表明,8组未经后处理的烟气中二噁英类浓度范围为52.01～332.97 ng/m3,总二噁英类毒性当量浓度范围为:1.27～5.14 ng TEQ/m3,2...文章对国内不同地区8台无后处理设备和2台带有后处理设备的火化炉烟气中二噁英类的排放情况进行了研究。结果表明,8组未经后处理的烟气中二噁英类浓度范围为52.01～332.97 ng/m3,总二噁英类毒性当量浓度范围为:1.27～5.14 ng TEQ/m3,2组经后处理设备的火化机烟气中二噁英类浓度分别为16.53 ng/m3,20 ng/m3,总二噁英类毒性当量浓度分别为0.39 ng TEQ/m3,0.28ng TEQ/m3,均已降低到国标要求的0.5 ng TEQ/m3限制以下。对火化烟气中二噁英类同系物的分析表明,氯代数目多的同系物浓度要低于氯代数目少的同系物浓度。此外,对4个火葬场周边土壤中二噁英浓度的测试表明,火葬场周边土壤中二噁英浓度低于多数国家对于居住地二英土壤浓度的限制。该研究为火化烟气污染治理的进一步研究奠定了基础。展开更多
Objective： The aim of this study was to investigate the prognostic factors and to evaluate the impact of adjuvant therapy on clinical outcome for early-stage cervical cancer. Methods： The clinical-pathological data ...Objective： The aim of this study was to investigate the prognostic factors and to evaluate the impact of adjuvant therapy on clinical outcome for early-stage cervical cancer. Methods： The clinical-pathological data of all 1,335 patients with the International Federation of Gynecology and Obstetrics （FIGO） Ib-[Ia cervical cancer treated with primary radical surgery at the Chinese National Cancer Center between May 2007 and Dec 2013 were retrospectively reviewed. The median follow-up was 70 months. Results： Of all the patients, 61.6% of the cases received adjuvant therapy, with 5-year disease-free survival （DFS） of 92.1% and 5-year overall survival （OS） of 95.0%. In multivariate analysis, differentiation of G3 （P〈0.05）, lymph node metastasis （LNM, P〈0.05） and lymphovascular space invasion （LVSI, P〈0.05） were independent predictors for OS, while LNM （P〈0.05）, deep stroma invasion （DSI, P〈0.05） and LVSI （P〈0.05） were independent factors for DFS. The samples were stratified by histologic type, and cervical squamous cell carcinoma （SCC） was found to share the same independent factors except for differentiation of OS. As to patients with cervical adenocarcinoma/adenosquamons carcinoma （AC/ASC）, differentiation was the independent predictor of OS （P〈0.05）; and LVSI of DFS （P〈0.05）. Of 236 patients with high-risk factors, there was no significant difference in survival between concurrent chemoradiotherapy （CCRT, n=195）, radiotherapy （RT, n=24）, and chemotherapy （CT, n=17）. Among the 190 patients with LNM who underwent CCRT, 124 cases showed improved DFS after sequential CT （P=0.118）, with a recurrence rate decrease of 14%, though the difference was not statistically significant. Patients with single intermediate-risk factors like DSI or LVSI were found to partially benefit from adjuvant therapy, but the difference was not statistically significant. Conclusions： LNM, LVSI, DSI and differentiation were found to be independent prognos展开更多
目的:系统评价Ki67表达比例对乳腺癌患者预后的影响,尤其是对无病生存期(DFS)的影响。为临床应用提供循证医学依据。方法:计算机检索PubMed、Embase、Web of Science、Cochrane Library、中国期刊全文数据库(CNKI)、维普数据库(VIP)、...目的:系统评价Ki67表达比例对乳腺癌患者预后的影响,尤其是对无病生存期(DFS)的影响。为临床应用提供循证医学依据。方法:计算机检索PubMed、Embase、Web of Science、Cochrane Library、中国期刊全文数据库(CNKI)、维普数据库(VIP)、万方数据库以及中国生物医学文献数据库(CBM)。应用RevMan 5.3软件对所纳入的数据进行统计学分析。结果:共纳入8篇文献,合计15 643例患者。Meta分析结果显示,纳入文献中的Ki67高比例表达组患者的DFS(HR=1.86,95%CI=1.31～2.65)要低于Ki67低比例表达组,差异有统计学意义。亚组分析中,以种族分亚组的结果与上述类似,差异也有统计学意义;以Ki67表达临界值分亚组,Ki67表达临界值为30%的亚组差异没有统计学意义,表达临界值为其他值的亚组差异有统计学意义。结论:本研究Meta分析显示,Ki67是乳腺癌的一种不良预后因子,Ki67高比例表达的患者有着更低的DFS。展开更多
文摘文章对国内不同地区8台无后处理设备和2台带有后处理设备的火化炉烟气中二噁英类的排放情况进行了研究。结果表明,8组未经后处理的烟气中二噁英类浓度范围为52.01～332.97 ng/m3,总二噁英类毒性当量浓度范围为:1.27～5.14 ng TEQ/m3,2组经后处理设备的火化机烟气中二噁英类浓度分别为16.53 ng/m3,20 ng/m3,总二噁英类毒性当量浓度分别为0.39 ng TEQ/m3,0.28ng TEQ/m3,均已降低到国标要求的0.5 ng TEQ/m3限制以下。对火化烟气中二噁英类同系物的分析表明,氯代数目多的同系物浓度要低于氯代数目少的同系物浓度。此外,对4个火葬场周边土壤中二噁英浓度的测试表明,火葬场周边土壤中二噁英浓度低于多数国家对于居住地二英土壤浓度的限制。该研究为火化烟气污染治理的进一步研究奠定了基础。
文摘Objective： The aim of this study was to investigate the prognostic factors and to evaluate the impact of adjuvant therapy on clinical outcome for early-stage cervical cancer. Methods： The clinical-pathological data of all 1,335 patients with the International Federation of Gynecology and Obstetrics （FIGO） Ib-[Ia cervical cancer treated with primary radical surgery at the Chinese National Cancer Center between May 2007 and Dec 2013 were retrospectively reviewed. The median follow-up was 70 months. Results： Of all the patients, 61.6% of the cases received adjuvant therapy, with 5-year disease-free survival （DFS） of 92.1% and 5-year overall survival （OS） of 95.0%. In multivariate analysis, differentiation of G3 （P〈0.05）, lymph node metastasis （LNM, P〈0.05） and lymphovascular space invasion （LVSI, P〈0.05） were independent predictors for OS, while LNM （P〈0.05）, deep stroma invasion （DSI, P〈0.05） and LVSI （P〈0.05） were independent factors for DFS. The samples were stratified by histologic type, and cervical squamous cell carcinoma （SCC） was found to share the same independent factors except for differentiation of OS. As to patients with cervical adenocarcinoma/adenosquamons carcinoma （AC/ASC）, differentiation was the independent predictor of OS （P〈0.05）; and LVSI of DFS （P〈0.05）. Of 236 patients with high-risk factors, there was no significant difference in survival between concurrent chemoradiotherapy （CCRT, n=195）, radiotherapy （RT, n=24）, and chemotherapy （CT, n=17）. Among the 190 patients with LNM who underwent CCRT, 124 cases showed improved DFS after sequential CT （P=0.118）, with a recurrence rate decrease of 14%, though the difference was not statistically significant. Patients with single intermediate-risk factors like DSI or LVSI were found to partially benefit from adjuvant therapy, but the difference was not statistically significant. Conclusions： LNM, LVSI, DSI and differentiation were found to be independent prognos
